PAC-1 receptor targeted therapeutic (Tectra)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePAC-1 receptor targeted therapeutic (Tectra)
Drug Alias Namepituitary adenylate cyclase-activating polypeptide type I receptor targeted therapeutic (Tectra)
ClassificationBiologics
Mechanisms of ActionBrain adenylate cyclase 1 modulators
TargetsBrain adenylate cyclase 1
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTectra
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTectra
Active IndicationsN/A
Inactive IndicationsMigraine Disorders

Other Information

ATC CodeN/A
Related LinksN/A